Shandong kexing biological products co., Ltd. from Shenzhen kexing bio-engineering co., Ltd. wholly-owned establishment, mainly responsible genetic engineering drugs, drug development, industrialization and commercialization of micro-ecological preparation operation tasks of high-tech bio-pharmaceutical companies. the Shandong kexing biological products co., Ltd. was established in 1997, is located in the zone, Mingshui, zhangqiu city, Shandong province, has a 118-acre garden plant.

company advocates and time synchronization of mainstream culture and humanistic spirit of enterprise, adhere to competitive human resource policy, focusing on software development and integration of resources, gradually cultivate the core competitiveness of enterprises, determined to build ideas, passion, strength, social responsibility, and sustainable development of high speed and high efficiency of Evergreen pharmaceutical enterprises. adhere to the "development and rely on people" philosophy, through the establishment and implementation of a competitive human resource policies, to allow the company to have fully met the corporate strategy and corporate development goals required human resources, establishing company personnel; on the other hand will make employees more thinking, more rational, more efficient, more productive, more confidence in the community.

Shandong kexing biological products co., Ltd. products have been included in the national torch plan, national plan of drug development fund, also included in the top ten in Shandong province high-tech projects, and second prize of Ministry of science and technology, medicine, Shandong province science and technology progress first grade Prize, France technology quality supervision and Evaluation Committee evaluated the quality products in China, total profits of pharmaceutical enterprises in Shandong province top 100 units. more than 10 years since its establishment, the product line of the company have passed the national GMP certification, and smoothly pass on Indonesia, and Brazil, and Egypt, Pakistan and other countries of the GMP certification.

  Shandong kexing biological products co., Ltd. has the original value of more than 100 million yuan in bio-pharmaceutical equipment, has the international advanced level of expression system of eukaryotic cells and prokaryotic expression system of two products of genetic engineering and professional production line with an annual output of 400 million tablets (bag) micro-ecological preparations (capsules, powder) oral preparations of production plant and the corresponding ancillary facilities, With strong technical strength and rich experience in production management, perfect quality assurance.

Shandong kexing biological products co., Ltd. 's main business is in puding County, white, three Chang Lekang products production and sales. to injection of recombinant human erythropoietin (rh-EPO) (trade name: puding) is put on the market in the first genetically engineered drug, has filled the country blank, indicates that China became the fourth in the world after the United States, Japan, Germany succeeded in developing countries, an end to foreign occupation and monopoly of the product on the market in China. puding 1997 first rh-EPO new drug certificate issued by the Chinese Ministry of health, the first GMP certificates, the company product quality and output of the EPO project in the domestic leading level.

 , and recombinant human granulocyte colony-stimulating factor (rhg-CSF) (trade names: Bai Texi) was successfully developed and produced by the company after the puding, a genetically engineered drug. G-CSF is the successful development of a 90 's one of the important factors in hematopoietic cells, the first 30 years of the 21st century, no comparable product replacement, the market is very optimistic about the future.

third leading products of the company put on the market is the exclusive new micro-ecological preparation of casein by oral administration of Clostridium and double live Bifidobacterium preparation (trade name: Chang Lekang), new drug development fund is included in the national plan for a class of new drugs, the project by the SME technology innovation fund project funding, with independent intellectual property rights, Invention patent number 9,711,509,3.1, patent protection period of 12 years.

nearly five years of steady growth in the performance of the company, company image, market reputation and constantly improving, market development of glad tidings keep pouring in.2003 year, the company successfully carried out with India, and Egypt, Indonesia, the Philippines, Pakistan, Brazil, business.2007 year, new start registration countries/regions of Iran, and Chile, and Venezuela, and Syria, have established a relatively stable export channels and partnerships, and "biological" brand enjoys a certain reputation in the international market.

in actively implementing "going out" strategy Beach International bio-pharmaceutical market at the same time, companies size up the situation, actively expand domestic markets, has over more than 30 provinces in China to build up their own marketing network and team of experts, increased market share, Shandong kexing brand is being more and more praise and trust of patients and clinicians.